| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZNF609_0010700 | Exon-Exon | chr15:64974275-64974440 | chr15:64682076-64682241 | 166 nt | 0.5422 |
| hsa_chr15_0219500 | Intergenic-Intergenic | chr15:64974681-64974938 | chr15:64682482-64682739 | 258 nt | 0.5698 |
| hsa_ZNF609_0010800 | Exon-Exon | chr15:64975355-64975555 | chr15:64683156-64683356 | 201 nt | 0.4876 |
| hsa_ZNF609_0010900 | Exon-Exon | chr15:64976263-64976405 | chr15:64684064-64684206 | 143 nt | 0.5175 |
| hsa_chr15_0219600 | Intergenic-Intergenic | chr15:64977643-64977826 | chr15:64685444-64685627 | 184 nt | 0.5598 |
A study in mice demonstrated that the circZNF609 exhibits higher expression in myotubes compared to myoblasts, and its downregulation reduces myoblast proliferation while inhibiting differentiation by sponging miR-194-5p and upregulating BCLAF1 [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review consolidating research across multiple species, including human, mouse, rat, and C. elegans, indicates that the circZNF609 is downregulated in Hirschsprung disease and functions as a miRNA sponge for miR-150-5p to regulate AKT3, where its silencing inhibits cell migration and proliferation [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. In mammalian neural tissue, it is also noted to play a role in myoblast differentiation by producing a protein [Suresh L. Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].